CN104324143A - 一种治疗淋巴结核的中药组合物 - Google Patents
一种治疗淋巴结核的中药组合物 Download PDFInfo
- Publication number
- CN104324143A CN104324143A CN201410567086.6A CN201410567086A CN104324143A CN 104324143 A CN104324143 A CN 104324143A CN 201410567086 A CN201410567086 A CN 201410567086A CN 104324143 A CN104324143 A CN 104324143A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- sargassum
- rhizoma pinelliae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 201000007227 lymph node tuberculosis Diseases 0.000 title abstract description 27
- 235000021419 vinegar Nutrition 0.000 claims abstract description 14
- 239000000052 vinegar Substances 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 11
- 240000004371 Panax ginseng Species 0.000 claims description 22
- 235000002789 Panax ginseng Nutrition 0.000 claims description 22
- 241000195474 Sargassum Species 0.000 claims description 22
- 235000008434 ginseng Nutrition 0.000 claims description 22
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 230000003203 everyday effect Effects 0.000 claims description 9
- 235000012054 meals Nutrition 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 22
- 210000004072 lung Anatomy 0.000 abstract description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 14
- 208000026435 phlegm Diseases 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000008961 swelling Effects 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 210000000582 semen Anatomy 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 3
- 241001474374 Blennius Species 0.000 abstract 3
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 3
- 241000045403 Astragalus propinquus Species 0.000 abstract 2
- 241000237502 Ostreidae Species 0.000 abstract 2
- 241000270666 Testudines Species 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 235000020636 oyster Nutrition 0.000 abstract 2
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000019606 astringent taste Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 208000033809 Suppuration Diseases 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 206010037660 Pyrexia Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 230000035876 healing Effects 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 239000003172 expectorant agent Substances 0.000 description 9
- 230000003419 expectorant effect Effects 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 239000010985 leather Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010060891 General symptom Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001415145 Acnistus arborescens Species 0.000 description 1
- FVVDKUPCWXUVNP-UHFFFAOYSA-M Aminosalicylate sodium anhydrous Chemical compound [Na+].NC1=CC=C(C([O-])=O)C(O)=C1 FVVDKUPCWXUVNP-UHFFFAOYSA-M 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940046927 sodium aminosalicylate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属中药技术领域,为解决现有西医治疗颈淋巴结核效果不理想且副作用较大的问题,提供一种治疗淋巴结核的中药组合物。方1由玄参、醋鳖甲、地骨皮、海藻、昆布、生牡蛎、半枝莲、黄芪、血丹参按一定比例制备而成;方2由陈皮、清半夏、云茯苓、炒白芥子、昆布、海藻、海浮石、血丹参按一定比例制备而成的。以玄参、昆布、清半夏为君药,凉血滋阴,软坚散结,消痞散结收敛固涩。以半枝莲,黄芪、血丹参、炒白芥子为臣药,消肿化瘀,补气固表,活血通经。以醋鳖甲,地骨皮、海浮石为佐药,滋阴潜阳,清肺降火,清火通淋;以海藻,生牡蛎、云茯苓为使药,消痰利水,重镇安神。诸药共奏达到治疗淋巴结核的作用,疗效显著,有效率可以达到90%。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗淋巴结核的中药组合物。
背景技术
淋巴结核,中医称之为瘰疬,民间俗称的“疬子颈”或“老鼠疮”,“瘰疬”之名始见于二千多年前《黄帝内经》灵枢·寒热篇:“寒热瘰疬,在于颈腋者”在颈部皮肉间可扪及大小不等的核块,其小者为瘰,大者为疬,因其互相串连,连贯如串珠状,故称之为瘰疬。本病特点多见于青壮年,初起如豆,不觉疼痛,逐渐增多,累累如串珠状,成脓时皮色转为暗红,溃后脓水清稀,往往此愈彼破,形成窦道,状如老鼠洞。治疗颇为棘手,在旧社会,有“十疬九死”之说。随着医学的不断进步,该病已不再可怕。瘰疬科就是以治疗这类疾病为特长的专科,并以“瘰疬”二字作为科室的名称。中医所称“瘰疬”和民间俗称“老鼠疮”,均指淋巴结核。淋巴结核以颈部为最常见,颈部淋巴结核还可合并纵隔肺门部、腋窝部、腹股沟部淋巴结核。瘰疬病是一种常见的慢性病,也是一种最苦恼的病,极大地危害着患者的身体健康和生命安全。
瘰疬的病理病因:中医认为,瘰疬病的病机多为本虚标实,虚者为肝肾亏虚,或气血亏虚,髓海不足,清窍失养。实者为风、火、痰淤痹阻经脉。临床实践认为瘰疬病为本虚标实,其病机多以气血亏虚,肝肾阴虚为本,肝阳上亢,流血阻络为标。由于性情不畅,脚气郁结,“火而化火内燔,以致炼液成痰,痰火上升结于颈项”逐成此证。病多后期,肝炎愈旺,下火乐肾阴,或脓水淋漓,耗气伤血,故往往转入捐途。此外,又有先因肺肾阴亏,以致水亏火旺,肺津不能输布,灼津为谈,痰火凝结,亦可形成本病。
病症:初期:初起时在颈项部结核如豆,一枚或数枚不等,渐渐窜生,皮色不变,按之坚实,既不疼痛,亦不发热。如久治不愈,则渐或疼痛,肿核亦逐渐增大。中期:结核增大,皮核粘连,推之不动,疼痛加甚,如皮色渐转暗红,皮肤微热,按之有应指感者,为内脓已成。病情严重者,结核往往延及凳下或胸腋等处。后期:溃破之后,脓水清稀,每多夹有败絮状物,疮内腐肉色呈灰白,一时不易随脓排尽。如处理得当,大约2—3月左右,可以收口。如疮口久不收敛,周围皮色紫暗凹陷,脓水淋漓不断者,则已形成漏管;或此愈彼溃,甚则延及缺盆胸腋等处;或收口之后,每因体虚而复发。如日久不愈,肝肾亏损,气血虚弱,此时,可有潮热骨蒸、咳嗽盗汗、精神倦怠,头昏失眠、胃内不佳、形体消瘦、脉象细致等虚劳之证。若先由肺肾阴亏所致者,则这些全身证状初期即可显露。总之,本病结核如延至数年,仍按之能动,县既不破溃,也不长大的,其病较轻;如初期即累累数枚,坚肿不移,并粘连在一起的,则其病较重。
西医治疗治疗颈淋巴结核时,对病情较轻的结节型或者浸润型且无全身症状的病人,一般只采用口服异烟肼1~2年;伴有全身毒性症状或身体他处有结核病变者,加服对氨水杨酸钠或利福平或加用肌肉注射。而对已有脓肿或者溃疡型的病人,既要采用外科手术切除并结合抗痨药物冲洗,同时还要服用抗结核药物。淋巴结核复发率高,西医多用治疗肺结核的药品治疗淋巴结核,效果都不理想,同时对肝、肾功能影响也较大。手术治疗易复发,故手术治疗及西医西药治疗都不能达到理想的效果。
发明内容
本发明为了解决现有西医治疗颈淋巴结核效果不理想且副作用较大的问题,提供了一种治疗淋巴结核的中药组合物。
本发明由如下技术方案实现的:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参15-25份、醋鳖甲5-15份、地骨皮15-25份、海藻5-15份、昆布5-15份、生牡蛎15-25份、半枝莲5-15份、黄芪15-25份、血丹参10-20份;方2:陈皮5-15份、清半夏5-15份、炒白芥子10-20份、昆布10-15份、海藻10-15份、海浮石10-20份、血丹参10-20份;所述方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。
本发明所述的中药制剂的各组分的优选配比方案是:方1:玄参20份,醋鳖甲10份,地骨皮20份,海藻10份,昆布10份,生牡蛎20份,半枝莲10份,黄芪20份、血丹参15份;方2:陈皮10份,清半夏10份,云茯苓10份,炒白芥子15份,昆布12份,海藻12份,海浮石15份,血丹参15份。
本发明中药制剂中:玄参:性甘、苦、咸,微寒;归肺、胃、肾经;凉血滋阴,泻火解毒。用于热病伤阴,舌绛烦渴,温毒发斑,津伤便秘,骨蒸劳嗽,目赤,咽痛,瘰疠,白喉,痈肿疮毒。醋鳖甲:性咸,微寒;归肝、肾经;滋阴潜阳,软坚散结,退热除蒸。用于阴虚发热,劳热骨蒸,虚风内动,经闭,癓瘕,久疟疟母。地骨皮性甘、寒;归肺、肝、肾经;凉血除蒸,清肺降火;用于阴虚潮热,骨蒸盗汗,肺热咳嗽,咯血,衄血,内热消渴。海藻:性苦、咸、寒;归肝、胃、肾经;软坚散结,消痰,利水。用于瘿瘤,瘰疬、睾丸肿痛,痰饮水肿。昆布:性咸、寒;归肝、胃、肾经;软坚散结,消痰,利水。用于瘿瘤,瘰疬,睾丸肿痛,痰饮水肿。生牡蛎:性咸、微寒;归肝、胆、肾经;重镇安神,潜阳补阴,软坚散结。用于惊悸失眠,眩晕耳鸣,瘰疬痰核,症瘕痞块。煅牡蛎收敛固涩。用于自汗盗汗,遗精崩带,胃痛吞酸。半枝莲:性辛、苦、寒;归肺、肝、肾经;清热解毒,化瘀利尿;用于疔疮肿毒,咽喉肿痛,毒蛇咬伤,跌扑伤痛,水肿,黄疸。黄芪:性甘、温;归肺、脾经;补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。血丹参:性苦、微寒;归心、肝经;祛瘀止痛,活血通经,清心除烦;用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。陈皮:性苦、辛、温;归肺、脾经;理气健脾,燥湿化痰。用于胸脘胀满,食少吐泻,咳嗽痰多。清半夏:味辛、温;有毒;归脾、胃、肺经;燥湿化痰,降逆止呕,消痞散结;用于痰多咳喘,痰饮眩悸,风痰眩晕,痰厥头痛,呕吐反胃,胸脘痞闷,梅核气;生用外治痈肿痰核。姜半夏多用于降逆止呕。炒白芥子:性辛;温;归肺;肝;脾;胃;心包经;化痰逐饮;散结消肿;主咳喘痰多、胸满胁痛、肢体麻木、关节肿痛、湿痰流注、阴疽肿毒。海浮石:性咸、寒;入肺、肾经;清肺火,化老痰,软坚,通淋;治痰热喘嗽,老痰积块,瘿瘤,瘰疬,淋病,疝气,疮肿,目翳。
本发明组方的配伍关系为:以玄参、昆布、清半夏为君药,凉血滋阴,软坚散结,消痞散结收敛固涩。以半枝莲,黄芪、血丹参、炒白芥子为臣药,消肿化瘀,补气固表,活血通经。以醋鳖甲,地骨皮、海浮石为佐药,滋阴潜阳,清肺降火,清火通淋;以海藻,生牡蛎、云茯苓为使药,消痰利水,重镇安神。诸药共奏达到治疗淋巴结核的作用。
本发明所述中药用于临床的情况如下:2000年8月至2014年6月期间患者1000例,其中男600例,女400例,病程至少半年。患者每日服用实施例2药物,方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。1个疗程后观察疗效。
诊断依据:根据《中华人民共和国中医药行业标准——中医病证诊断疗效标准(ZY/T001.1-94)》的规定,参考“瘰疬的诊断依据”,初起颈部一侧或两侧有单个或多个核状肿块,推之可移,皮色不变,亦不疼痛;病情发展,核块与皮肤粘连,有轻度疼痛。化脓时皮色转为暗红,肿块变软,脓肿破溃后脓液稀薄,夹有败絮样物。疮口潜行,久不愈合,可形成窦道。可有肺痨病史或肺痨病接触史。结核菌素试验强阳性,血沉降率增快。病理活捡可助诊断。
疗效评定:根据《中华人民共和国中医药行业标准——中医病证诊断疗效标准(ZY/T001.1-94)》的规定,参考“瘰疬的疗效评定”,治愈:肿块消散或窦道愈合,全身症状消失。好转:肿块缩小或窦道脓水减少,全身症状改善。未愈:肿块不消,窦道不愈合,全身症状未改善。
治疗方法:方1:取玄参20g,醋鳖甲10g,地骨皮20g,海藻10g,昆布10g,生牡蛎20g,半枝莲10g,黄芪20g、血丹参15g;方2:陈皮10g,清半夏10g,云茯苓10g,炒白芥子15份,昆布12份,海藻12份,海浮石15份,血丹参15份。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。1个疗程后观察疗效。
治疗结果:治愈者800例占80%,好转者100例占10%,未愈者100例占10%。总有效率达90%。使用本发明其他实施例与使用本实施例2的治疗效果无显著差异。
典型病例:
1.沁水县郑庄乡杨某,男45岁,患者于2000年就诊,诊为颈淋巴结核,淋巴结炎,皮下脂肪瘤等,腹部下肿块两枚,诊为脂肪瘤。曾经抗痨治疗未消。诊脉弦细,舌质红,证属阴虚火旺,灼律成痰,痰浊凝结。服用本发明药物1个疗程后症状减缓,继续服用本发明药物1个疗程症状完全消失,再服用1个疗程巩固疗效,瘰疬尽消,随访至今未复发。
2.赵某,女38岁,患者于1992年腊月发现右侧颈部出现一核桃大小的包块,诊为淋巴结核,手术治疗3次,但是隔年或次年又复发。2001年于我院就诊,服用本发明实施例2药物1个疗程后包块消失,继续服药2个疗程,症状完全消失,再次服药1个疗程巩固疗效,随访至今未复发。
3.李某,男,45岁,患者于2011年初发现脖子两边长了很多包块,确诊为淋巴结核,中医针灸治疗4个月后包块不退反大,且伴空洞性肺结核,多次治疗无果,2012年于我院就诊,服用本发明实施例2药物1个疗程后包块变小,继续服用本发明实施例2药物2个疗程,包块消失,然后再服药2个疗程巩固疗效,随访至今未复发。
具体实施方式
以下结合实施例对本发明做进一步详细描述。
实施例1:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参15g、醋鳖甲5g、地骨皮15g、海藻5g、昆布15g、生牡蛎25g、半枝莲5g、黄芪15g、血丹参10g;方2:陈皮15g、清半夏12g、云茯苓15g、炒白芥子12g、昆布10g、海藻10g、海浮石12g、血丹参20g。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。1个疗程后观察疗效。本实施例所制药物,同样采用上述的诊断依据、疗效标准以及治疗方法进行临床试验,对300名患者(其中男164女136)进行治疗,治疗结果:治愈者228例占76%、好转者39例占13%、未治愈者33例占11%。总有效率达89%。
实施例2:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参20份,醋鳖甲10份,地骨皮20份,海藻10份,昆布10份,生牡蛎20份,半枝莲10份,黄芪20份、血丹参15份;方2:陈皮10份,清半夏10份,云茯苓10份,炒白芥子15份,昆布12份,海藻12份,海浮石15份,血丹参15份。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。1个疗程后观察疗效。
实施例3:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参25g、醋鳖甲12g、地骨皮25g、海藻8g、昆布5g、生牡蛎22g、半枝莲15g、黄芪18g、血丹参20g;方2:陈皮5g、清半夏5g、云茯苓9g、炒白芥子20g、昆布14g、海藻15g、海浮石10g、血丹参14g。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。本实施例所制药物,同样采用上述的诊断依据、疗效标准以及治疗方法进行临床试验,对288名患者(其中男124女164)进行治疗,治疗结果:治愈者228例占79.17%、好转者24例占8.33%、未治愈者36例占12.5%。总有效率达87.5%。
实施例4:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参22g、醋鳖甲15g、地骨皮15g、海藻15g、昆布12g、生牡蛎15g、半枝莲8g、黄芪25g、血丹参16g;方2:陈皮8g、清半夏15g、云茯苓8g、炒白芥子10g、昆布15g、海藻10g、海浮石20g、血丹参10g。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。本实施例所制药物,同样采用上述的诊断依据、疗效标准以及治疗方法进行临床试验,对185名患者(其中男98女87)进行治疗,治疗结果:治愈者139例占75.14%、好转者24例占12.97%、未治愈者22例占11.89%。总有效率达88.11%。
实施例5:一种治疗淋巴结核的中药组合物,由下列重量份的原料制成:方1:玄参25g、醋鳖甲5g、地骨皮18g、海藻5g、昆布15g、生牡蛎25g、半枝莲5g、黄芪15g、血丹参20g;方2:陈皮15g、清半夏5g、云茯苓13g、炒白芥子10g、昆布15g、海藻13g、海浮石10g、血丹参20g。方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。本实施例所制药物,同样采用上述的诊断依据、疗效标准以及治疗方法进行临床试验,对428名患者(其中男220女208)进行治疗,治疗结果:治愈者334例占78.04%、好转者47例占10.98%、未治愈者47例占10.98%。总有效率达89.02%。
Claims (2)
1.一种治疗淋巴结核的中药组合物,其特征在于:由下列重量份的原料制成:方1:玄参15-25份、醋鳖甲5-15份、地骨皮15-25份、海藻5-15份、昆布5-15份、生牡蛎15-25份、半枝莲5-15份、黄芪15-25份、血丹参10-20份;方2:陈皮5-15份、清半夏5-15份、云茯苓8-15份、炒白芥子10-20份、昆布10-15份、海藻10-15份、海浮石10-20份、血丹参10-20份;所述方1和方2中的药物分别常规水煎,方1和方2间隔服用,每方两天服用1剂,1剂分4次服用,药液每天早晚服用1次,餐后服用,14天为一个疗程。
2.根据权利要1所述的一种治疗淋巴结核的中药组合物,其特征在于:由下列重量份的原料制成:方1:玄参20份,醋鳖甲10份,地骨皮20份,海藻10份,昆布10份,生牡蛎20份,半枝莲10份,黄芪20份、血丹参15份;方2:陈皮10份,清半夏10份,云茯苓10份,炒白芥子15份,昆布12份,海藻12份,海浮石15份,血丹参15份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410567086.6A CN104324143B (zh) | 2014-10-23 | 2014-10-23 | 一种治疗淋巴结核的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410567086.6A CN104324143B (zh) | 2014-10-23 | 2014-10-23 | 一种治疗淋巴结核的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104324143A true CN104324143A (zh) | 2015-02-04 |
CN104324143B CN104324143B (zh) | 2018-08-10 |
Family
ID=52399033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410567086.6A Active CN104324143B (zh) | 2014-10-23 | 2014-10-23 | 一种治疗淋巴结核的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104324143B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106611A (zh) * | 2015-08-13 | 2015-12-02 | 黄先成 | 一种治疗淋巴结核的外用中药 |
CN107496738A (zh) * | 2017-08-31 | 2017-12-22 | 夏季 | 一种治疗淋巴结核的药物及其制备方法 |
CN115737748A (zh) * | 2022-11-18 | 2023-03-07 | 上海市肺科医院 | 一种治疗淋巴结核的外敷药 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188615A (zh) * | 2011-04-19 | 2011-09-21 | 张海英 | 一种淋巴结核的治疗方法 |
-
2014
- 2014-10-23 CN CN201410567086.6A patent/CN104324143B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188615A (zh) * | 2011-04-19 | 2011-09-21 | 张海英 | 一种淋巴结核的治疗方法 |
Non-Patent Citations (1)
Title |
---|
魏睦新等: "《名中医治疗难治性外科病奇方妙法》", 30 November 2005, 科学技术文献出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106611A (zh) * | 2015-08-13 | 2015-12-02 | 黄先成 | 一种治疗淋巴结核的外用中药 |
CN107496738A (zh) * | 2017-08-31 | 2017-12-22 | 夏季 | 一种治疗淋巴结核的药物及其制备方法 |
CN115737748A (zh) * | 2022-11-18 | 2023-03-07 | 上海市肺科医院 | 一种治疗淋巴结核的外敷药 |
CN115737748B (zh) * | 2022-11-18 | 2023-09-12 | 上海市肺科医院 | 一种治疗淋巴结核的外敷药 |
Also Published As
Publication number | Publication date |
---|---|
CN104324143B (zh) | 2018-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN103638386A (zh) | 一种治疗风寒湿痹的药物及其制备方法 | |
CN104324143A (zh) | 一种治疗淋巴结核的中药组合物 | |
CN104888178A (zh) | 一种治疗小儿腹泻的中药 | |
CN101912552B (zh) | 一种治疗小腿溃疡的中药制剂 | |
CN104815105A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 | |
CN107823497A (zh) | 一种治疗多发性疖肿的药物及其制备方法 | |
CN103638403B (zh) | 一种治疗糖尿病肢端坏疽的药物及其制备方法 | |
CN104524278A (zh) | 一种治疗脑梗塞的中药组合物 | |
CN106620408A (zh) | 一种治疗恶性葡萄胎的药物及其制备方法 | |
CN101564510A (zh) | 一种有效治疗鹅掌风的中药擦剂 | |
CN104721630A (zh) | 一种用于麻醉催醒的中药制剂及制备方法 | |
CN104435853A (zh) | 一种治疗冠心病的中药组合物 | |
CN105833074A (zh) | 治疗口腔溃疡的中药组合物 | |
CN104324269A (zh) | 治疗舌癌的中药组合物及其制备方法 | |
CN105125836A (zh) | 一种治疗结节性红斑的汤剂药物及其制备方法 | |
CN104689086A (zh) | 一种治疗口腔溃疡的复方中药冲剂及其制备方法 | |
CN104435855A (zh) | 一种治疗病毒性心肌炎的中药组合物 | |
CN104096099A (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN102526626B (zh) | 一种治疗食道癌的药物及其制备方法 | |
CN104547653A (zh) | 一种治疗慢性鼻窦炎的中药组方 | |
CN111202790A (zh) | 一种治疗感冒的中药 | |
CN107260884A (zh) | 一种可有效治疗中风的丸剂药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190115 Address after: 100020 2309, 20th floor, 237 North Chaoyang Road, Chaoyang District, Beijing Patentee after: Wanbang Hanfang (Beijing) Pharmaceutical Science and Technology Research Co., Ltd. Address before: 048100 Guohe Village, Xihe Township, Yangcheng County, Jincheng City, Shanxi Province Patentee before: Song Qunku |